XML 29 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Income Statement [Abstract]    
Sales-net of slotting fees and discounts $ 93,187,621 $ 47,083,740
Costs of sales 73,769,359 35,229,867
Gross profit 19,418,262 11,853,873
Operating expenses:    
Research and development 135,141 120,692
General and administrative 16,461,467 11,650,414
Total operating expenses 16,596,608 11,771,106
Income from operations 2,821,654 82,767
Other income (expenses)    
Interest (633,889) (73,487)
Amortization of debt discount (22,121) (2,438)
Other income 2,648 37,704
Total other income (expenses) (653,362) (38,221)
Net income before income tax provision and income from equity method investment 2,168,292 44,546
Income from equity method investment 143,486
Income tax provision (9,104) (296,472)
Net income (loss) 2,302,674 (251,926)
Less: series B preferred dividends (34,070)
Net income (loss) available to common stockholders $ 2,268,604 $ (251,926)
Net income (loss) per common share    
– basic $ 0.06 $ (0.01)
– diluted $ 0.06 $ (0.01)
Weighted average common shares outstanding    
– basic 36,093,858 35,702,197
– diluted 37,313,178 35,702,197